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864This study describes the spectrum of CMR ﬁndings
in a cohort of ARVD/C-associated mutation carriers,
including ﬁrst-degree relatives of ARVD/C patients
who were “at risk” of disease. Our study has several
important ﬁndings. First, in ARVD/C mutation car-
riers with structural disease on CMR, biventricular
abnormalities were seen with similar frequency to
isolated RV disease. Involvement of the LV in subjects
with ARVD/C has been increasingly recognized, with
prevalence reported in up to 80% of ARVD/C patients
in several European populations (1,2) and 40% in a
cohort of North American and Dutch patients (4). Our
study conﬁrms the high prevalence of biventricular
disease in North American patients with structurally
abnormal hearts and genetic predisposition to
ARVD/C. Interestingly, though, LV abnormalities
were not detrimental to cardiac function with no
signiﬁcant differences between groups with and
without LV involvement. Furthermore, demographic
and RV ﬁndings were similar between individuals
with isolated RV disease and those with biventricular
disease, suggesting that LV abnormalities may occur
at any stage of RV disease and are not limited only to
subjects with advanced RV disease. This ﬁnding ar-
gues against the traditional notion that LV abnor-
malities are a late complication of the disease (5).
More likely, there is a spectrum of the disease process
that varies from patient to patient, extending across
both ventricles. Finally, the only ﬁnding signiﬁcantly
different between subjects with isolated RV disease
and those with LV abnormalities was genotype, sug-
gesting an association between genotype and struc-
tural phenotype in ARVD/C mutation carriers.Neda Rastegar, MD
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Measurement in Healthy VolunteersTricuspid valve (TV) anatomy and function play an
important prognostic role in several heart diseases
and in the development of functional tricuspid
regurgitation. According to current guidelines for
management of heart valve disease, the tricuspid
annulus (TA) diameter measured by 2-dimensional
transthoracic echocardiography (2DE) should be used
to deﬁne the need of an associated TA annuloplasty
in patients undergoing cardiac surgery for left-sided
heart valve diseases (1,2). However, the timing dur-
ing the cardiac cycle when the TA should be measured
remains to be established. Moreover, normative data
about TA diameter and function are limited (3–5).
Therefore, we designed a prospective cross-
sectional study of 219 normal volunteers (age 43 
15 years; 57% female; body mass index <30 kg/m2)
to assess the variability of TA diameter measurement
in 2DE 4-chamber view (4CH) in relation to timing
during the cardiac cycle.
The TA diameter was obtained from the apical right
ventricular (RV)–focused 4CH using a Vivid E9 (GE
Vingmed, Horten, Norway) equipped with M5S probe
and measured as the distance between the insertion
points of the TV leaﬂets (inner edge to inner edge) at 5
time points during the cardiac cycle. The times during
the cardiac cycle were determined using both elec-
trocardiogram and valve dynamic visualization: TV
closure (end-diastole—the ﬁrst frame after the TV
closure), mid-systole (beginning of T-wave), end-
systole (end of T-wave), TV opening early ﬁlling (as
the frame with the TV wide open during passive ﬂow),
TV opening late ﬁlling (as the frame with the TV
wide open during active ﬂow—after P-wave).
FIGURE 1 Tricuspid Annulus Diameter Variability in Healthy Volunteers Obtained From Apical Right Ventricular–Focused 4-Chamber View
(Left) absolute values. (Right) values indexed to body surface area. Whisker lengths 2 SD from the mean value. TV ¼ tricuspid valve.
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865Fractional shortening (FS) of the TA diameter was
calculated using the largest and smallest diameters
and expressed as a percentage. Right atrial (RA) and RV
volumes were obtained using 3DE full-volume data-
sets acquired with a 4V matrix-array transducer (GE
Vingmed) and measured using dedicated software
designed for volumetric analysis of the left atrium (LA
and RV analysis, Tomtec Imaging Systems, Unters-
chleissheim, Germany).
The feasibility of measuring the TA diameter in 4CH
by 2DE was 99.5%. Absolute TA diameters were sig-
niﬁcantly larger in men than in women. However, this
difference was eliminated after indexation by body
surface area (Figure 1). In healthy subjects, the TA
diameter increased from mid-systole to early diastole
and then decreased (FS 24.16.2%;D 8.02.4mm; p<
0.001), with a consistent correlation with the phasic
changes of RA (r¼0.56; p< 0.001) and RV volumes (r¼
0.53; p<0.001), and height (r¼0.49; p<0.001), weight
(r ¼ 0.54; p < 0.001). At multivariate linear regression
analysis, age (r2 ¼ 0.2; p < 0.001), sex (r2 ¼ 0.2; p ¼
0.002), and RA (r2 ¼ 0.45; p < 0.001) and RV volumes
(r2¼0.2; p<0.001)were independently correlatedwith
TA absolute diameters and accounted for 55% of the
variance of mid-systolic TA diameter in the 4CH view.
Applying the cutoff values for TA annuloplasty
proposed in the current guidelines and in published
reports (TA >40 mm or FS <25%) (1,2,4) to our study
population resulted in a signiﬁcant number of our
healthy subjects fulﬁlling 1 or more criteria for
intervention: 19.7% with dilated early diastolic TA in
4CH view (95% conﬁdence interval: 14.4 to 25) and58% with reduced FS in the 4CH view (95% conﬁ-
dence interval: 51.2 to 64.4).
It is well known that the complex geometry of the
TA is difﬁcult to assess by a tomographic imaging
technique like 2DE. However, current guidelines
recommend 2DE to assess TA size and indicate the
need for tricuspid annuloplasty. The present study
provided reference values for TA diameter obtained
in the 4CH view speciﬁc for 2DE and identiﬁed the
main determinants of TA size. Age, sex, and right
chamber sizes, as well as the timing during the car-
diac cycle, signiﬁcantly inﬂuence the TA diameter in
4CH in healthy individuals. According to our data, TA
evaluation to deﬁne the need for TV annuloplasty
should include diameter measurements at both
mid-systole and early diastole, complemented with
right heart chamber volumes. Our data may help to
correctly identify TA enlargement by 2DE.Marcelo Haertel Miglioranza, MD, PhD
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Valve-in-Valve and Pulmonary Valve
ImplantationPatients with surgically treated congenital cardiac
disease increasingly survive into adulthood and face
the need for repeat sternotomies for senescent pros-
thetic valves and conduits. This poses increased risk
of chest re-entry injury, and alternatives to redo
median sternotomy are important. Although trans-
catheter aortic valve-in-valve (ViV) and transcatheter
pulmonary valve implantation (TPVI) (Melody valve,
Medtronic, Minneapolis, Minnesota) have both been
separately described (1–3), we describe a combination
of aortic ViV and TPVI utilizing 3-dimensional (3D)
computed tomography (CT) ﬂuoroscopic coregistra-
tion to aid procedural execution. A 24-year-old man
with congenital bicuspid aortic stenosis, prior Ross
procedure, re-replacement of the right ventricle–
pulmonary artery homograft, ascending aortic aneu-
rysm repair, and aortic valve replacement (25-mm
Perimount bioprosthesis, Edwards Lifesciences,
Irvine, California) was referred for symptomatic
aortic and pulmonary conduit stenoses. Aortic valve
mean gradient was 52 mm Hg, and mean pulmonary
conduit gradient was 38 mm Hg. CT demonstrated
pulmonary conduit stenosis and an aortic annular
area of 360 mm2 (annular dimensions 21.9 mm 
21.5 mm). The distances of the right coronaryartery origin and proximal left anterior descending
artery from the pulmonary artery were 8.7 mm and
11.9 mm, respectively. Coronary artery relational
anatomy was felt to be favorable for intervention
with combined transcatheter aortic ViV and TPVI
(Figure 1A).
Using standard techniques, a 26-mm transcatheter
aortic valve replacement (Sapien-XT, Edwards Life-
sciences) was successfully undertaken within the
aortic prosthesis. Post-deployment echocardiographic
assessment demonstrated normal valve function. A
noncontrast rotational angiogram of the cardiac and
vascular structures was then performed, and images
were matched with previously performed CT re-
constructions of the pulmonary conduit. Coregistra-
tion using known skeletal landmarks enabled overlay
of 3D images onto live ﬂuoroscopy to guide trans-
catheter pulmonary valve placement. An exchange-
length stiff guidewire was placed in the left lower
lobe pulmonary artery using a balloon wedge catheter,
and serial balloon dilations of the pulmonary conduit
were performed using 18- and 22-mm balloons with
simultaneous left coronary angiography demon-
strating no coronary–conduit interaction. A 22-mm
diameter balloon-in-balloon “BIB” catheter (NuMed,
Hopkinton, New Jersey) with a mounted stent (Pal-
maz-XL-4010, Cordis, Bridgewater, New Jersey) was
delivered via a 14-Fr Mullins sheath into the pulmo-
nary conduit. This was used to expand the homograft
conduit and prepare a landing zone to minimize future
risk of transcatheter pulmonary valve stent fracture.
Fluoroscopic and 3D CT overlay facilitated accurate
positioning and deployment of the stent. The stentwas
then post-dilated using a 22-mm balloon, and no stent
recoil was noted. A 22-mm transcatheter pulmonary
valve was then successfully deployed using a 22-mm
delivery system (Ensemble delivery system, Med-
tronic) within the landing zone created by the stent
(Figures 1B and 1C). The peak-to-peak catheter right
ventricular outﬂow tract (RVOT) gradient was reduced
to 5 mm Hg. Transesophageal echocardiography
showed normal valve function with mild regurgita-
tion. The patient was dismissed from the hospital on
day 2 with a mean transaortic gradient of 21 mm Hg,
and 11 mm Hg across the RVOT, with no demonstrable
regurgitation.
This presentation is unique in that this was a young
adult with 3 previous median sternotomies within a
period of 6 years, and efforts to avoid a repeated me-
dian sternotomy were critical. Multidisciplinary
assessment and 3D imaging were essential to proce-
dural planning and execution. Although annular
calciﬁcation and radiographic signatures of prosthetic
valves can often serve as ﬂuoroscopic markers and
